Description: | (Pro3) GIP, human TFA is an efficacious, stable and specific�human GIP receptor (hGIPR)�full agonist. (Pro3) GIP, human TFA has high binding affinity for human GIPR with Ki/ Kd value of 0.90 nM. (Pro3) GIP, human TFA human can be used for the research of obesity-related diabetes[1][2]. |